Sichuan, China

Tao Gong


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tao Gong in Tumor Targeting

Introduction

Tao Gong is a notable inventor based in Sichuan, China. He has made significant contributions to the field of medical science, particularly in the development of targeted therapies for tumors. His innovative work focuses on the creation of polypeptides that can effectively target tumor cells and associated structures.

Latest Patents

Tao Gong holds a patent for a polypeptide designed to target tumors. This invention involves an nRGD polypeptide formed by connecting alanine-alanine-asparagine (AAN) with a polypeptide containing arginine-glycine-aspartic acid (RGD). The nRGD polypeptide is capable of targeting tumor vessels, tumor cells, and tumor-associated macrophages, facilitating the targeted delivery of therapeutic agents to tumors.

Career Highlights

Throughout his career, Tao Gong has been associated with prominent institutions such as Sichuan University and Yaopharma Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Tao Gong has collaborated with esteemed colleagues, including Zhirong Zhang and Yan Zhang. These partnerships have enhanced his research efforts and fostered innovation in the field of tumor targeting.

Conclusion

Tao Gong's contributions to the development of tumor-targeting polypeptides represent a significant advancement in cancer therapy. His innovative approach and collaborative efforts continue to influence the medical research landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…